Johnson & JohnsonJNJ
$271.29+0.95%+2.5600Spread: 32.89
Pharmaceuticals · MCap: $654.49B
MA:||
Open
$265.70
High
$272.75
Low
$264.78
Prev Close
$268.73
Volume
267,251
SMA 20
$227.61
SMA 50
$232.89
RSI (14)
60.9
ATR (14)
$3.97
Avg Vol (20d)
267,755
Prior Close
$230.31
H: $233.19 L: 229.08
Bollinger Bands
U $235.03M $227.61L $220.19
MACD
Line -0.0714Signal -1.1281Hist 1.0567
Recent News
Cyclicals Lead Sectors In Wednesday Trading As Real Estate Trails
benzinga · 10/28/2026
Leerink Partners Maintains Buy Rating on Johnson & Johnson
fiscal.ai · 10/28/2026
Johnson & Johnson to Host Enterprise Business Review
fiscal.ai · 10/27/2026
Mark Cuban Warns CEOs If Your Health Benefits Do Not Actually Help Employees You Are Legally Liable - 'It’s All On You’
benzinga · 10/26/2026
Johnson & Johnson Reports Phase 1b/2 Results for Subcutaneous Amivantamab in Head and Neck Cancer
fiscal.ai · 10/26/2026
Johnson & Johnson Reports Positive Phase 1 Results for JNJ-6143 in Advanced Prostate Cancer
fiscal.ai · 10/25/2026
Johnson & Johnson Announces Positive Phase 3 PROTEUS Substudy Results for Prostate Cancer Treatment
fiscal.ai · 10/24/2026
UK Regulator Approves Johnson & Johnson's Oral Psoriasis Treatment
fiscal.ai · 10/23/2026
European Commission Approves TECVAYLI® Indication Extension for Multiple Myeloma
fiscal.ai · 10/23/2026
Johnson & Johnson Orthopedics Merger Talks with Smith & Nephew Collapse
fiscal.ai · 10/23/2026